Summary:
Could it be better?
Viveve is conducting a clinical trial to test the safety and effectiveness of the Geneveve Treatment.
Geneveve is being evaluated as a treatment for women who are having decreased sexual experiences after childbirth, including problems with arousal, desire, lubrication, orgasm and pain during sex.
Qualified Participants Must:
• Be at least 18 years old and premenopausal
•
Have experienced at least one vaginal delivery six months or longer before joining the study
•
Have had sexual dysfunction since giving birth
*Other conditions may apply
Qualified Participants May Receive:
-Geneveve Treatment or placebo treatment at no cost
-Compensation for time and travel
-Study related care from a board-certified physician at no cost
The VIVEVE II study is a clinical trial evaluating the Geneveve Treatment as an investigational treatment for female sexual dysfunction. This is not a commercial treatment.